Pfizer-BioNTech Covid-19 Vaccine for Kids Was Safe and 90.7% Effective, Companies Say

U.S. health regulators are expected to weigh in soon on the evidence for giving the Pfizer-BioNTech Covid-19 vaccine to children 5 to 11 years old.